New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2014
07:07 EDTSLXPSalix price target raised to $127 from $106 at Piper Jaffray
Piper Jaffray raised its price target for Salix Pharmaceuticals shares to $127 following the company's Q4 results citing strong visibility on continued growth for Xifaxan. Piper reiterates an Overweight rating on the stock.
News For SLXP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SLXP

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use